Drug recall D-0493-2017
Product
Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20
Reason for recall
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled
Lots and codes
Batch #3083289; Exp. Date 12/2018
Recall details
- Recalling firm
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL
- Quantity
- 58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each)
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 27, 2017
- Terminated
- March 15, 2019
Related products
- Mirtazapine – drug information
- NDC 51079-087 Mirtazapine · Mirtazapine 30 mg/1 · Mylan Institutional Inc.
- NDC 51079-086 Mirtazapine · Mirtazapine 15 mg/1 · Mylan Institutional Inc.
- NDC 51079-088 Mirtazapine · Mirtazapine 45 mg/1 · Mylan Institutional Inc.